Regeneron Pharmaceuticals, Inc. (REGN): EPS (Diluted)
$41.48
Year ended 2025-12-31
+2.8%
3-year compound annual growth
+6.3%
5-year compound annual growth
+22.3%
10-year compound annual growth
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $41.48 | +8.2% | 2026-02-04, From 2025-01-01 |
| 2024-12-31 | $38.34 | +10.3% | 2026-02-04, From 2024-01-01 |
| 2023-12-31 | $34.77 | -9.0% | 2026-02-04, From 2023-01-01 |
| 2022-12-31 | $38.22 | -46.9% | 2025-02-05, From 2022-01-01 |
| 2021-12-31 | $71.97 | +135.8% | 2024-02-05, From 2021-01-01 |
| 2020-12-31 | $30.52 | +65.3% | 2023-02-06, From 2020-01-01 |
| 2019-12-31 | $18.46 | -13.3% | 2022-02-07, From 2019-01-01 |
| 2018-12-31 | $21.29 | +105.9% | 2021-02-08, From 2018-01-01 |
| 2017-12-31 | $10.34 | +34.3% | 2020-02-07, From 2017-01-01 |
| 2016-12-31 | $7.70 | +39.5% | 2019-02-07, From 2016-01-01 |
| 2015-12-31 | $5.52 | +85.2% | 2018-02-08, From 2015-01-01 |
| 2014-12-31 | $2.98 | -19.9% | 2017-02-09, From 2014-01-01 |
| 2013-12-31 | $3.72 | n/c | 2016-02-11, From 2013-01-01 |
| 2012-12-31 | $6.75 | n/m | 2015-02-12, From 2012-01-01 |
| 2011-12-31 | -$2.45 | n/m | 2014-02-13, From 2011-01-01 |
| 2010-12-31 | -$1.26 | n/a | 2013-02-15, From 2010-01-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $41.48 | +8.2% |
| Viatris Inc (VTRS) | 2025-12-31 | -$3.00 | n/m |
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $15.32 | n/m |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $1.21 | n/m |
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $0.42 | n/m |
| Zoetis Inc. (ZTS) | 2025-12-31 | $6.02 | +10.1% |
| Organon & Co. (OGN) | 2025-12-31 | $0.72 | -78.4% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $0.19 | n/m |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | -$0.47 | n/m |
Compare REGN, VTRS, VRTX, TEVA side by side · Screen every company in Pharmaceutical Preparations ↗